SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
SRC Family Kinase Inhibition in Ewing Sarcoma Cells Induces p38 MAP Kinase-Mediated Cytotoxicity and Reduces Cell Migration
Authors
Keywords
-
Journal
JOURNAL OF CELLULAR PHYSIOLOGY
Volume 232, Issue 1, Pages 129-135
Publisher
Wiley
Online
2016-04-03
DOI
10.1002/jcp.25397
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- SRC Family Kinase Inhibition Through a New Pyrazolo[3,4-d]Pyrimidine Derivative as a Feasible Approach for Glioblastoma Treatment
- (2015) Elisa Ceccherini et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CD99 regulates neural differentiation of Ewing sarcoma cells through miR-34a-Notch-mediated control of NF-κB signaling
- (2015) S Ventura et al. ONCOGENE
- RB1 dual role in proliferation and apoptosis: cell fate control and implications for cancer therapy
- (2015) Paola Indovina et al. Oncotarget
- SRC family kinase (SFK) inhibition reduces rhabdomyosarcoma cell growth in vitro and in vivo and triggers p38 MAP kinase-mediated differentiation
- (2015) Nadia Casini et al. Oncotarget
- Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma
- (2014) J. Ban et al. CANCER RESEARCH
- The Genomic Landscape of Pediatric Ewing Sarcoma
- (2014) B. D. Crompton et al. Cancer Discovery
- Genomic Landscape of Ewing Sarcoma Defines an Aggressive Subtype with Co-Association of STAG2 and TP53 Mutations
- (2014) F. Tirode et al. Cancer Discovery
- The Genomic Landscape of the Ewing Sarcoma Family of Tumors Reveals Recurrent STAG2 Mutation
- (2014) Andrew S. Brohl et al. PLoS Genetics
- Design, Synthesis, and Biological Evaluation of Pyrazolo[3,4-d]pyrimidines Active in Vivo on the Bcr-Abl T315I Mutant
- (2013) Marco Radi et al. JOURNAL OF MEDICINAL CHEMISTRY
- Notch signaling in pediatric soft tissue sarcomas
- (2012) Rossella Rota et al. BMC Medicine
- Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition
- (2012) Martina Cozzi et al. CELL CYCLE
- Emerging roles of RB family: New defense mechanisms against tumor progression
- (2012) Paola Indovina et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group
- (2012) Richard B. Womer et al. JOURNAL OF CLINICAL ONCOLOGY
- The Tyrosine Kinase c-Src Directly Mediates Growth Factor-Induced Notch-1 and Furin Interaction and Notch-1 Activation in Pancreatic Cancer Cells
- (2012) Yong-Chao Ma et al. PLoS One
- Inhibition of Notch3 signalling induces rhabdomyosarcoma cell differentiation promoting p38 phosphorylation and p21Cip1 expression and hampers tumour cell growth in vitro and in vivo
- (2011) L Raimondi et al. CELL DEATH AND DIFFERENTIATION
- New pyrazolo[3,4-d]pyrimidine SRC inhibitors induce apoptosis in mesothelioma cell lines through p27 nuclear stabilization
- (2011) P Indovina et al. ONCOGENE
- Fenretinide-dependent upregulation of death receptors through ASK1 and p38α enhances death receptor ligand-induced cell death in Ewing's sarcoma family of tumours
- (2010) D E White et al. BRITISH JOURNAL OF CANCER
- Novel dual Src/Abl inhibitors for hematologic and solid malignancies
- (2010) Silvia Schenone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Long-term Survivors of Childhood Ewing Sarcoma: Report From the Childhood Cancer Survivor Study
- (2010) J. P. Ginsberg et al. JNCI-Journal of the National Cancer Institute
- Fyn is induced by Ras/PI3K/Akt signaling and is required for enhanced invasion/migration
- (2010) Vipin Yadav et al. MOLECULAR CARCINOGENESIS
- Downstream EWS/FLI1 - upstream Ewing's sarcoma
- (2010) Heinrich Kovar Genome Medicine
- Ewing's sarcoma of the bone: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
- (2009) M. Paulussen et al. ANNALS OF ONCOLOGY
- Advances in Ewing's Sarcoma Research: Where Are We Now and What Lies Ahead?
- (2009) J. L. Ordonez et al. CANCER RESEARCH
- Dose-Intensified Compared With Standard Chemotherapy for Nonmetastatic Ewing Sarcoma Family of Tumors: A Children's Oncology Group Study
- (2009) Linda Granowetter et al. JOURNAL OF CLINICAL ONCOLOGY
- A Molecular Function Map of Ewing's Sarcoma
- (2009) Maximilian Kauer et al. PLoS One
- EWS-FLI1 Suppresses NOTCH-Activated p53 in Ewing's Sarcoma
- (2008) J. Ban et al. CANCER RESEARCH
- Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells
- (2008) Adriano Spreafico et al. FASEB JOURNAL
- Src Directly Phosphorylates Bif-1 and Prevents Its Interaction with Bax and the Initiation of Anoikis
- (2008) Hirohito Yamaguchi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma
- (2008) H. Guan et al. MOLECULAR CANCER THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started